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Abstract 
Purpose: To monitor the changes in nitric oxide levels and synovium thickness index in synovial fluid 
following intra-articular injection of sodium hyaluronate. 
Methods: One hundred patients diagnosed with osteoarthritis of the knee from April 2014 to January 
2015 in The Third Hospital of Jinan, Jinan, Shandong, China were selected and categorized into three 
phases; namely, mild, moderate and severe. Patients received a 20 mL sodium hyaluronate injection 
into the articular cavity of the knee once per week for 15 weeks, with continuous observation. The 
Visual Analogue Scale (VAS) and Western Ontario and McMaster University Osteoarthritis Index 
(WOMAC) scores were recorded after five weeks. A total of 56 patients (78 knees) remaining in serious 
condition after 5 weeks were divided into mild, moderate, and severe groups and treated with sodium 
hyaluronate once a week. Internationally reorganized VAS and WOMAC scores were adopted as 
clinical observation indices to indicate the curative effect of sodium hyaluronate among the 56 patients 
after 15 weeks of treatment. The conditions of the patients in the two phases were compared. 
Results: After 5 weeks of treatment, treatment effective rate in the mild, moderate and severe groups 
was 72.92, 66.10 and 28.57 %, respectively, with an overall effective rate of 78 %. After 15 weeks of 
treatment, treatment effective rate in mild, moderate, and severe groups was 96.77, 95.45 and 66.67 %, 
respectively, with an overall effective rate of 67.95 %. 
Conclusions: Clinically curative effect of sodium hyaluronate is significant for mild and moderate phase 
patients after intra-articular injection of sodium hyaluronate, while the effect is insignificant in severe 
patients. Thus, sodium hyaluronate can effectively improve nitric oxide levels in synovial fluid, reduce 
synovium thickness, enhances articular cavity lubrication and effectively alleviates disease severity. 
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Sodium hyaluronate is the major component of 
synovial fluid and one of the components of 
cartilage matrix. In patients with osteoarthritis, 
intra-articular injection of sodium hyaluronate can 
effectively improve articular cavity lubrication, 
covers and protects the cartilago articularis, 
improves joint contracture, inhibits degeneration 
changes on the cartilage surface, improves 
pathological joint fluid, and enhances articular 
cavity lubrication. With the aging population 
growing each year, the number of patients with 
knee osteoarthritis is increasing. Patients with 
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knee osteoarthritis suffer from several 
detrimental symptoms, including knee joint pain, 
swelling, and limitation of activity. 
 
Several groups have demonstrated that sodium 
hyaluronate has a lasting pain-relieving effect 
among patients with knee osteoarthritis, and this 
effect has been observed clinically. Chen et al [1] 
treated knee osteoarthritis by injecting sodium 
hyaluronate into the articular cavity of 484 
patients (610 knees) and evaluated the effect of 
treatment using the Lysholm’s knee score. The 
overall treatment success rate was 67.8 %. 
However, this effect was not observed among 
severely affected patients, and further work 
showed that a combination of surgery and drugs 
might be indicated for these patients [2]. 
 
Concurrent joint mobilization and intra-articular 
sodium hyaluronate injection may not only 
improve the effects of sodium hyaluronate 
treatment, but may also reduce pain and improve 
the effusion quantity and motion of joints in 
patients with knee osteoarthritis. Liu et al [3] 
treated patients with rheumatoid arthritis with oral 
NSAIDs and immunosuppressants with 
concurrent sodium hyaluronate injections of the 
knee joint. Although the treatment was generally 
successful, the onset of symptom relief was slow 
and of limited effect. 
 
Nevertheless, local articular cavity treatment may 
control inflammatory responses and rapidly 
relieve joint pain. Therefore, Ma and Wang 
assessed the curative effect of applying Jintiange 
capsules together with sodium hyaluronate 
among 80 patients with knee osteoarthritis [4]. 
Using diagnostic criteria recommended by 
American College of Rheumatology, they 
confirmed that this treatment combination worked 






One hundred patients in our hospital (121 knees) 
diagnosed with knee osteoarthritis from April 
2014 to January 2015 in The Third Hospital of 
Jinan, Jinan, Shandong, China were selected for 
this study. Approval for the study was given by 
the institutional ethical committee. There were 54 
males (62 knees) and 46 females (59 knees). 
Patients were grouped by disease severity after 
5 weeks of treatment (Table 1) and re-evaluated 




For treatment with sodium hyaluronate, patients 
were seated with their knee joints fully exposed 
and at 90o angle. Iodine and ether were applied 
to the skin to sterilize the puncture point, and any 
synovial fluid present in the knee joint was 
extracted prior to the injection of 20 mL sodium 
hyaluronate. Injections were performed weekly 
for 15 weeks. The effect of treatment was 
evaluated via range of motion of the knee joint. 
 
Main outcome measures 
 
Measurement of NO levels in joint fluid: To 
examine nitric oxide (NO) levels in the joint fluid, 
1 mL of fluid was extracted from the knee joint of 
each patient prior to treatment and each week of 
treatment. NO levels were determined nitrate 
reductase method and a spectrophotometer. NO 
levels were determined after 5 weeks and 15 
weeks of treatment. 
 
Ultrasonic testing of synovium thickness: GE 
LOGIQEQ ultrasound equipment (General 
Electric, Fairfield, CT, USA) together with the 
linear probe ML6-15 were used for ultrasonic 
inspection of knee join synovium thickness. 
Patients maintained their knee joints at a 30-
degree angle during the procedure, which was 
performed on transverse and vertical sections of 
the suprapatellar bursa. Synovium thickness was 
measure before treatment and after 5 and 15 
weeks of treatment. All patients were examined 




The Western Ontario and McMaster University 
Osteoarthritis Index (WOMAC) scoring standard 
was proposed and adopted clinically in 1988 [9]. 
This scoring system categorizes the severity of 
hip and knee arthritis and the curative effect of 
treatment in terms of some related symptoms 
and signs The Visual Analogue Scale (VAS) was 
used to record scores. 
 
Table 1: Distribution of patients in disease severity groups after 15 weeks of treatment 
 
Group  Male (32 cases, 43 knees) Female (24 cases, 35 knees) 
Mild  11 cases, 15 knees 7 cases, 11 knees 
Moderate  18 cases, 23 knees 15 cases, 20 knees 
Severe  3 cases, 5 knees 2 cases, 4 knees 
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A straight line or ruler 10 cm in length is shown to 
patients, who mark the level of their pain or 
limited functional level on the line/ruler (0=least 
severe, 10=most sever). The scoring index of 
WOMAC joint inflammation is shown in Table 2. 
 
Table 2: WOMAC scoring index for joint inflammation 
 
Pain 
1. Walk on flat ground 
2. Walk upstairs or downstairs 
3. Pain that disturbs sleep on the bad at night 
4. Sit or lie down 
Stiffness 
6. Severity of stiff after waking up in the 
morning 
7. Severity of stiff after sitting, lying down and 
rest at a later period  
Difficulty in carrying out daily activities 
8. Walk downstairs 
9. Walk upstairs 
10. Stand up after sitting 
11. Stand up 
12. Bend towards the ground 
13. Get in and out of the car or get on and off 
the bus 
14. Shop outside 
15. Wear socks or stockings 
16. Get up from the bed 
17. Take off socks or stockings 
18. Lie in bed 
19. Get in and out of the bath 
20. While sitting 
21. Squat down or stand up in toilet 
22. Do heavy housework 
23. Do light housework 
Note: VAS is adopted to evaluate the index; a higher 
WOMAC index (score) indicates more severe 
osteoarthritis (OA). The degree of OA is determined by 
the total score: Mild < 80, moderate = 80 – 120; 




Data are presented as the mean ± standard 
deviation. Differences between mean scores 
were tested using Student’s t-test with SPSS 
13.0 software. Differences were considered 




Overall therapeutic effect of hyaluronate 
injection 
 
After 5 weeks of treatment, hyaluronate 
injections were effective in 72.92 % of mild 
group, 66.10 % of moderate group, and 28.57 % 
of severe group patients with an overall effective 
rate of 78 % (Table 3). After 15 weeks, treatment 
was effective in 96.77 % of mild group, 95.45 % 
of moderate groups, and 66.67 % of severe 
group patients, with an overall effective rate of 
67.95 % (Table 4). 
 
Changes in synovial fluid NO levels 
 
Synovial fluid NO levels in patients with mild, 
moderate and severe knee osteoarthritis 
significantly improved after both 5 weeks and 15 
weeks of treatment compared to baseline levels 
(before treatment; Table 5). Additionally, levels 
were significantly improved at 15 weeks of 




As illustrated in Table 6, the effect of sodium 
hyaluronate treatment was significant by 5 weeks 
of treatment, and as shown in Table 7, although 
this effect was maintained through all 15 weeks 
of treatment, the effect was less significant in 
later weeks than during the first 5 weeks. 
Table 3: Clinical outcome after 5 weeks of treatment 
 
Group  
No. of knees Significant effect Efficient  Inefficient Effective rate Male 
54 
Female 
46 Male  Female  Male  Female  Male  Female  
Mild  27 21 10 11 10 4 4 6 72.92 % 
Moderate  28 31 10 11 9 9 9 9 66.10 % 
Severe  7 7 1 0 2 1 4 4 28.57 % 
 
Table 4: Clinical outcome after 15 weeks of treatment 
 
Groups  No. of knees Significant effect Efficient Inefficient Effective rate Male 43 Female 35 Male  Female  Male  Female  Male  Female  
Mild  16 15 7 10 8 5 1 0 96.77 % 
Moderate  12 10 7 6 3 5 2 1 95.45 % 
Severe  2 1 0 0 1 1 1 0 66.67 % 
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Table 5: Synovial fluid NO levels (µmol/L) after 5 weeks of treatment 
 
Group  No. of knees Before treatment 5 weeks later t P-value 
Mild  48 76.96 ± 23.51 50.29 ± 20.12 4.56 0.002 
Moderate  59 93.73 ± 48.29 72.23 ± 32.41 4.69 0 
Severe  14 145.34 ± 68.32 122.33 ± 54.12 4.72 0.001 
 
Table 6: Comparison of WOMAC Scores pre- and post (5 weeks) treatment 
 
Group  No. of knees Before treatment   5 weeks  
Mild  48 77.58 ± 10.38 40 ± 9.56 
Moderate  59 98 ± 12.54 51 ± 11.25 
Severe  14 132 ± 16.35 116 ± 12.68 
 
Table 7: WOMAC scores after 5 and 15 weeks of treatment 
 
Group  No. of knees 5 weeks 15 weeks 
Mild  31 73 ± 10.16 51 ± 9.11 
Moderate  22 93 ± 14.35 77 ± 9.86 




Osteoarthritis is a chronic disease with a higher 
incidence rate among the elderly. The major 
clinical manifestations of the disease include 
pain, swelling, limitation of activity limitation, and 
clicking of the knee joint, which severely reduce 
the quality of life of patients. Osteoarthritis in the 
cartilage articularis first manifests as a 
progressive degeneration of the cartilage and 
reduction in sodium hyaluronate in the articular 
cavity, which results in the abnormal function of 
synovial fluid and leads to osteosclerosis of the 
subchondral bone and finally the formation of 
bone proliferation in the bond edge [5-7]. 
 
In this study, we demonstrated that the 
mechanism of action of sodium hyaluronate 
includes the improvement of joint fluid secretion, 
reduction in synovial fluid NO levels, and a 
decrease in synovium thickness. Additionally, 
injecting sodium hyaluronate into articular cavity 
may relieve inflammation, inhibit joint 
deterioration due to disease, and relieve pain, 
swelling, and activity limitation by promoting 
circulation in the joints and the recovery of knee 
joint function [8]. 
 
Nitrate concentrations were high in the joint fluid 
of knee osteoarthritis patients, and the inducible 
nitric oxide synthase inhibitor L-NMMA reduced 
the production of nitrates in tissue, indicating the 
production of NO in the joint fluid. Other groups 
have reported a serious imbalance in free radical 
metabolism in patients with knee osteoarthritis, 
resulting in widespread tissue damage in these 
patients. NO is a highly reactive free radical with 
a role in the regulation of blood pressure, nerve 
conduction, and host defense by killing bacteria, 
fungi, and cancer cells. Conversely, it can cause 
injury to normal tissues. Upon chondrocyte injury, 
the synthetic rate of nitric oxide synthase 
(cNOS)-and subsequently NO levels-increases 
[10,11]. NO is synthesized by inducible NO 
synthetase (iNOS), which can be activated by 
cytokines IL-1β, TNF-α, IFN-γ; therefore, NO 
may have a role in r bone pathological process 
associated with cytokine activation. 
 
The role of NO in the pathogenesis of knee 
osteoarthritis is gaining increased research 
attention. It has been found that iNOS inhibitors 
can effectively inhibit inflammatory lesions in the 
knee joint [12], improve local blood circulation, 
promote the cartilage repair, and reduce NO 
production in the knee joint, thus mitigating NO-
induced damage to the cartilago articularis. 
 
Sodium hyaluronate was first extracted from the 
bovine vitreous body in 1934 by Meyer et al [13], 
who described its role in pain suppression 
articular cartilage degeneration, the protection of 
articular tissue, the improvement of joint 
contracture and pathological joint fluid, and the 
promotion of the synthesis of more sodium 
hyaluronate in the synovial fluid. Sodium 
hyaluronate does not only prevent joint synovitis 
and cartilage degeneration, but it is also 
protective and reparative to degenerated 
synovial fluid and cartilage. The injection of 
sodium hyaluronate into the articular cavity has 
become an important prevention and 
complementary therapy for knee osteoarthritis 
[14]. Additionally, sodium hyaluronate can act to 
clear up cell debris generated from rapid 
metabolism in the joint. 
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After intra-articular sodium hyaluronate injection, 
the treatment success rate was higher in patients 
with mild symptoms; the effective treatment rate 
in this group reached 72.92 % after 5 weeks, 
while this rate was only 28.57 % in the severe 
group. The treatment success rate further 
improved after 15 weeks of treatment compared 
to 5 weeks of treatment; however, effective of the 
treatment was still not apparent. Therefore, 
sodium hyaluronate treatment proved more 
effective in patients with mild disease than in 
those with severe disease. For patients with 
severe disease, surgery and/or other drugs are 
indicated. 
 
We also observed a positive correlation between 
synovial fluid NO levels and clinical scores of 
knee osteoarthritis and synovium thickness. 
Additionally, NO levels were significantly reduced 
in all three disease groups (mild, moderate, and 
severe) after treatment with sodium hyaluronate. 
However, differences in synovium thickness were 
only significant in the moderate group, with no 
significant differences observed in the mild or 
severe group. This may indicate that knee 
articular cavity synovium in patients with mild 
osteoarthritis is close to normal levels and that 
sodium hyaluronate treatment relieves disease 
symptoms mainly by increasing articular synovial 
fluid metabolism [15]. However, as the synovium 
of patients with severe knee osteoarthritis is 
typically severely swollen, congested, full of 
lesions, sodium hyaluronate may be unable to 
penetrate the tissue, explaining the absent effect 




The findings of this study demonstrate that intra-
articulate injection of sodium hyaluronate into the 
knee joint has a positive effect on articular cavity 
NO levels, promotion of joint fluid secretion, 
increased joint lubrication, and effective 
restoration of synovium thickness, thus 
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